RICHMOND, Va.--(BUSINESS WIRE)--

First financial table, under the header "Six Months Ended June 30," the years should read 2016 and 2015 (instead of 2015 and 2014).

The corrected release reads:

OWENS & MINOR REPORTS 2^ND QUARTER 2016 FINANCIAL RESULTS

Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the second quarter ended June 30, 2016, including consolidated revenues of $2.48 billion, an increase of 2.5% when compared to revenues of $2.42 billion in the second quarter of 2015. Quarterly net income was $27.7 million, or $0.45 per diluted share, compared to $0.39 per diluted share in the second quarter of 2015. Quarterly adjusted net income (non-GAAP) was $32.2 million, or $0.52 per diluted share, compared to $0.46 per diluted share in last year's second quarter. The increase in net income per diluted share resulted from revenue growth and initiatives associated with the company's transformation agenda, including improved expense control. A reconciliation of reported results to adjusted (non-GAAP) measures is included among the schedules below.

Consolidated operating earnings for the second quarter of 2016 were $52.1 million, or 2.10% of revenues, representing an increase $4.2 million when compared to the second quarter last year. Adjusted consolidated operating earnings (non-GAAP) for the second quarter were $58.8 million, or 2.37% of revenues, an improvement of $5.2 million when compared to the same period last year.

"Our global teams remain focused on delivery of our 2016 plan and have performed well across our enterprise so far this year," said P. Cody Phipps, president & chief executive officer of Owens & Minor. "Our strategy of attacking complexity across the healthcare supply chain and creating value for our manufacturer and provider customers is gaining traction while we refine our strategies to drive sustained profitable growth. I am pleased with our execution and performance through the first half of this year."

2016 Year-to-Date Results

For the 2016 year-to-date period, Owens & Minor reported consolidated revenues of $4.94 billion, an increase of 2.6% when compared to revenues of $4.81 billion in the first half of 2015. Net income for the first six months of 2016 was $51.9 million, or $0.83 per diluted share, compared to $0.69 per diluted share in last year's first half. Adjusted net income (non-GAAP) was $63.5 million, or $1.02 per diluted share, compared to $0.90 per diluted share last year. The increase in net income per diluted share resulted from improved operating earnings in each of the company's segments.

Consolidated operating earnings for the first six months of 2016 were $97.0 million, or 1.96% of revenues, representing an increase of $8.2 million, when compared to the same period last year. Adjusted consolidated operating earnings (non-GAAP) for the year-to-date period improved $9.8 million to $114.3 million, or 2.31% of revenues.

Asset Management

At June 30, 2016, the balance of cash and cash equivalents was $139 million. For the first six months of 2016, the company reported cash provided by operating activities of $42.6 million. Asset management metrics for the quarter were strong with consolidated days sales outstanding (DSO) of 21.5 days, as of June 30, 2016. Consolidated inventory turns were 9.3 for the period.

Segment Results

Domestic segment revenues for the second quarter of 2016 were $2.35 billion, increased 2.9% when compared to the prior year's second quarter revenue. For the year-to-date period, Domestic segment revenues improved 3.0% to $4.67 billion, when compared to the same period last year. Revenue improvement for both periods resulted primarily from growth with large healthcare provider customers. An additional sales day in the first quarter of 2016 also contributed to the improvement in the year-to-date period. For the second quarter of 2016, Domestic segment operating earnings were $43.5 million, an improvement of $5.1 million when compared to the second quarter of 2015. For the year-to-date period, Domestic segment operating earnings were $85.2 million, improved 11.3% compared to the prior year. The improvements in operating earnings resulted primarily from revenue growth and expense control initiatives, partially offset by a year-over-year decline in income from manufacturer product price changes.

International segment revenues were $88.6 million for the second quarter of 2016, a decrease of $4.3 million in comparison to last year. For the first six months of 2016, International segment revenues declined $16.3 million to $172 million. Excluding the previously discussed exit of a U.K.-based customer last year and the negative impact of foreign exchange, revenues improved by $1.4 million for the quarter and declined $2.9 million year-to-date. For the second quarter of 2016, International segment operating earnings were $0.9 million, representing a decline of approximately $288 thousand over last year. For the year-to-date period, the International segment reported operating earnings of $2.0 million, improved $1.2 million from the prior year, as a result of improved performance in the U.K. and continued profitable results across the regions.

Clinical & Procedural Solutions (CPS) revenues for the second quarter were $135 million, representing a slight decline compared to the prior year quarter. For the year-to-date period, CPS reported revenues of $276 million, an increase of 4.1% over last year. Revenue growth benefitted from improved alignment with the sales efforts of our Domestic segment. Operating earnings for the CPS segment were $14.3 million for the quarter and $27.5 million year-to-date, both improved slightly when compared to last year's results.

"We are pleased with our second quarter performance and the continued progress made by our three segments during the second quarter," said Richard A. Meier, executive vice president & chief financial officer, and president-International of Owens & Minor. "At this point in the year, we believe the strong first half performance and our continued execution will offset much of the impact of the previously announced exit of a large healthcare provider customer. Therefore, we are affirming our financial outlook for the year."

2016 Outlook

The company affirmed its financial guidance for 2016 of adjusted earnings per diluted share in the range of $2.00 to $2.05.

Upcoming Investor Events

Owens & Minor is scheduled to participate in two investor conferences in the third quarter of 2016. Webcasts of formal presentations will be posted on the company's corporate website:

• Baird 2016 Global Healthcare Conference – September 7 – New York
• Wells Fargo 2016 Healthcare Conference – September 8 – Boston

Investors Conference Call & Supplemental Material

Conference Call: Owens & Minor will conduct a conference call for investors on Wednesday, August 3, 2016, at 8:30 a.m. EDT. The access code for the conference call, international dial-in and replay is #49423409. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. Replay: A replay of the call will be available for one week by dialing 855-859-2056. Webcast: A listen-only webcast of the call, along with supplemental information, will be available on www.owens-minor.com under "Investor Relations."

Owens & Minor uses its website as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under Investor Relations at www.owens-minor.com.

Safe Harbor Statement

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements, including those with respect to our 2016 Outlook, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to our annual report on Form 10-K for the year ended December 31, 2015, filed with the Securities and Exchange Commission ("SEC") and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. These filings are available at www.owens-minor.com. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

Owens & Minor, Inc. (NYSE: OMI) is a leading global healthcare services company dedicated to Connecting the World of Medical Products to the Point of Care^TM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. A FORTUNE 500 company, Owens & Minor is headquartered in Richmond, Virginia, and has annualized revenues exceeding $9 billion. For more information about Owens & Minor, visit the company website at owens-minor.com.

Owens & Minor, Inc. Consolidated Statements of Income (unaudited) (in thousands, except per share data)
		Three Months Ended June 30,
		2016				2015
Net revenue		$	2,483,676			$	2,422,167
Cost of goods sold		2,184,256				2,123,830
Gross margin		299,420				298,337
Distribution, selling and administrative expenses		242,914				246,958
Acquisition-related and exit and realignment charges		6,752				5,707
Other operating income, net		(2,300		)		(2,188		)
Operating earnings		52,054				47,860
Interest expense, net		6,765				6,680
Income before income taxes		45,289				41,180
Income tax provision		17,573				16,954
Net income		$	27,716			$	24,226
Net income per common share:
Basic		$	0.45			$	0.39
Diluted		$	0.45			$	0.39

			Six Months Ended June 30,
			2016				2015
Net revenue			$	4,939,469			$	4,813,363
Cost of goods sold			4,343,413				4,217,425
Gross margin			596,056				595,938
Distribution, selling and administrative expenses			485,639				496,652
Acquisition-related and exit and realignment charges			17,235				15,623
Other operating income, net			(3,842		)		(5,172		)
Operating earnings			97,024				88,835
Interest expense, net			13,554				13,560
Income before income taxes			83,470				75,275
Income tax provision			31,619				32,109
Net income			$	51,851			$	43,166
Net income per common share:
Basic			$	0.83			$	0.69
Diluted			$	0.83			$	0.69

Owens & Minor, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands)
		June 30, 2016				December 31, 2015
Assets
Current assets
Cash and cash equivalents		$	138,951			$	161,020
Accounts and notes receivable, net		609,212				587,935
Merchandise inventories		957,972				940,775
Other current assets		268,645				284,970
Total current assets		1,974,780				1,974,700
Property and equipment, net		201,519				208,930
Goodwill, net		418,366				419,619
Intangible assets, net		89,599				95,250
Other assets, net		71,800				75,277
Total assets		$	2,756,064			$	2,773,776
Liabilities and equity
Current liabilities
Accounts payable		$	775,970			$	710,609
Accrued payroll and related liabilities		28,268				45,907
Other current liabilities		239,887				307,073
Total current liabilities		1,044,125				1,063,589
Long-term debt, excluding current portion		566,955				568,495
Deferred income taxes		84,500				86,326
Other liabilities		64,187				62,776
Total liabilities		1,759,767				1,781,186
Total equity		996,297				992,590
Total liabilities and equity		$	2,756,064			$	2,773,776

Owens & Minor, Inc. Consolidated Statements of Cash Flows (unaudited) (in thousands)
		Six Months Ended June 30,
		2016				2015
Operating activities:
Net income		$	51,851			$	43,166
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization		28,343				36,138
Share-based compensation expense		5,969				5,048
Provision for losses on accounts and notes receivable		(27		)		41
Deferred income tax (benefit) expense		(2,071		)		2,992
Changes in operating assets and liabilities:
Accounts and notes receivable		(29,736		)		41,622
Merchandise inventories		(17,947		)		(31,866		)
Accounts payable		62,710				145,682
Net change in other assets and liabilities		(56,599		)		2,771
Other, net		145				1,196
Cash provided by operating activities		42,638				246,790
Investing activities:
Additions to property and equipment		(8,857		)		(12,009		)
Additions to computer software and intangible assets		(4,602		)		(10,816		)
Proceeds from sale of property and equipment		4,565				837
Cash used for investing activities		(8,894		)		(21,988		)
Financing activities:
Change in bank overdraft		—				1,530
Repayment of revolving credit facility		—				(33,700		)
Cash dividends paid		(32,003		)		(31,867		)
Repurchases of common stock		(20,849		)		(7,440		)
Excess tax benefits related to share-based compensation		598				457
Other, net		(5,968		)		(5,112		)
Cash used for financing activities		(58,222		)		(76,132		)
Effect of exchange rate changes on cash and cash equivalents		2,409				(4,473		)
Net increase (decrease) in cash and cash equivalents		(22,069		)		144,197
Cash and cash equivalents at beginning of period		161,020				56,772
Cash and cash equivalents at end of period		$	138,951			$	200,969

Owens & Minor, Inc. Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited) (in thousands, except per share data)
		Quarter Ended
(in thousands, except ratios and per share data)		6/30/2016				3/31/2016				12/31/2015				9/30/2015				6/30/2015
														.
Consolidated operating results:
Net revenue		$	2,483,676			$	2,455,793			$	2,487,914			$	2,471,669			$	2,422,167
Gross margin		$	299,420			$	296,636			$	312,282			$	306,354			$	298,337
Gross margin as a percent of revenue		12.06		%		12.08		%		12.55		%		12.39		%		12.32		%
Distribution, selling & admin expenses		$	242,914			$	242,725			$	250,172			$	246,959			$	246,958
Distribution, selling & admin expenses as a percent of revenue		9.78		%		9.88		%		10.06		%		9.99		%		10.20		%
Operating earnings, as reported (GAAP)		$	52,054			$	44,970			$	57,953			$	53,572			$	47,860
Acquisition-related charges (1)		730				(399		)		4,048				1,335				1,786
Exit and realignment charges (2)		6,022				10,882				2,599				4,799				3,921
Other (3)		—				—				(1,500		)		—				—
Operating earnings, adjusted (Non-GAAP)		$	58,806			$	55,453			$	63,100			$	59,706			$	53,567
Operating earnings as a percent of revenue, adjusted (Non-GAAP)		2.37		%		2.26		%		2.54		%		2.42		%		2.21		%
Net income, as reported (GAAP)		$	27,716			$	24,135			$	32,068			$	28,176			$	24,226
Acquisition-related charges (1)		730				(399		)		4,048				1,335				1,786
Income tax expense(benefit) (4)		(164		)		152				77				(236		)		(437		)
Exit and realignment charges (2)		6,022				10,882				2,599				4,799				3,921
Income tax expense(benefit) (4)		(2,081		)		(3,506		)		(2,163		)		(519		)		(401		)
Other (3)		—				—				(1,500		)		—				—
Income tax expense(benefit) (4)		—				—				—				—				—
Net income, adjusted (Non-GAAP)		$	32,223			$	31,264			$	35,129			$	33,555			$	29,095
Net income per diluted common share, as reported (GAAP)		$	0.45			$	0.39			$	0.51			$	0.45			$	0.39
Acquisition-related charges (1)		0.01				—				0.07				0.02				0.02
Exit and realignment charges (2)		0.06				0.11				—				0.07				0.05
Other (3)		—				—				(0.02		)		—				—
Net income per diluted common share, adjusted (Non-GAAP)		$	0.52			$	0.50			$	0.56			$	0.54			$	0.46
Financing:
Cash and cash equivalents		$	138,951			$	190,323			$	161,020			$	125,245			$	200,969
Total interest-bearing debt		$	571,143			$	572,318			$	573,522			$	574,304			$	575,065
Stock information:
Cash dividends per common share		$	0.255			$	0.255			$	0.2525			$	0.2525			$	0.2525
Stock price at quarter-end		$	37.38			$	40.42			$	35.98			$	31.94			$	34.00

Owens & Minor, Inc.

Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited)

The following items in the current quarter have been excluded in our non-GAAP financial measures:

⁽¹⁾ Acquisition-related charges in the second quarter of 2016 primarily relate to costs incurred to settle certain obligations and address other on-going matters associated with the acquisitions of ArcRoyal and Medical Action. Charges in the first quarter of 2016 related to the gain on the sale of property acquired with the Medical Action acquisition. Charges in 2015 consisted primarily of costs to continue the integration of Medical Action and ArcRoyal which were acquired in the fourth quarter of 2014 including certain severance and contractual payments to the former owner and costs to transition information technology and other administrative functions.

⁽²⁾ Charges in 2016 were associated with severance activities (including our voluntary employee separation program in the first quarter of 2016), and other costs associated with our strategic organizational realignment which include certain professional fees and costs to streamline administrative functions and processes in the United States and Europe. Similar charges in 2015 also included the consolidation of distribution and logistics centers and closure of offsite warehouses.

⁽³⁾ The fourth quarter of 2015 included a partial recovery of $1.5 million related to a contract settlement in the United Kingdom for which $3.9 million was expensed in 2014. Both the 2015 recovery and the 2014 settlement expense were recorded in other operating income, net.

⁽⁴⁾ These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes.

Use of Non-GAAP Measures

This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.'s (the "Company") core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company's performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company's performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

Owens & Minor, Inc. Summary Segment Information (unaudited) (in thousands)
		Three Months Ended June 30,
		2016								2015
						% of								% of
						consolidated								consolidated
		Amount				net revenue				Amount				net revenue
Net revenue:
Segment net revenue
Domestic		$	2,345,746			94.45	%			$	2,279,725			94.12	%
International		88,559				3.57	%			92,856				3.83	%
CPS		134,964				5.43	%			135,714				5.60	%
Total segment net revenue		2,569,269								2,508,295
Inter-segment revenue
CPS		(85,593		)		(3.45	)%			(86,128		)		(3.56	)%
Total inter-segment revenue		(85,593		)						(86,128		)
Consolidated net revenue		$	2,483,676			100.00		%		$	2,422,167			100.00		%
						% of segment								% of segment
Operating earnings (loss):						net revenue								net revenue
Domestic		$	43,451			1.85	%			$	38,394			1.68	%
International		893				1.01	%			1,181				1.27	%
CPS		14,255				10.56	%			13,850				10.21	%
Inter-segment eliminations		207								142
Acquisition-related and exit and realignment charges (1)		(6,752		)						(5,707		)
Consolidated operating earnings		$	52,054			2.10	%			$	47,860			1.98	%
Depreciation and amortization:
Domestic		$	7,497							$	8,888
International		4,416								4,743
CPS		2,213								2,150
Consolidated depreciation and amortization		$	14,126							$	15,781
Capital expenditures:
Domestic		$	2,659							$	3,349
International		2,860								7,875
CPS		880								35
Consolidated capital expenditures		$	6,399							$	11,259

Owens & Minor, Inc. Summary Segment Information (unaudited) (in thousands)
		Six Months Ended June 30,
		2016								2015
						% of								% of
						consolidated								consolidated
		Amount				net revenue				Amount				net revenue
Net revenue:
Segment net revenue
Domestic		$	4,667,455			94.49	%			$	4,529,430			94.10	%
International		172,110				3.48	%			188,367				3.91	%
CPS		276,317				5.59	%			265,359				5.51	%
Total segment net revenue		5,115,882								4,983,156
Inter-segment revenue
CPS		(176,413		)		(3.57	)%			(169,793		)		(3.53	)%
Total inter-segment revenue		(176,413		)						(169,793		)
Consolidated net revenue		$	4,939,469			100.00	%			$	4,813,363			100.00	%
						% of segment								% of segment
Operating earnings (loss):						net revenue								net revenue
Domestic		$	85,169			1.82	%			$	76,499			1.69	%
International		2,021				1.17	%			843				0.45	%
CPS		27,526				9.96	%			27,032				10.19	%
Inter-segment eliminations		(457		)						84
Acquisition-related and exit and realignment charges (1)		(17,235		)						(15,623		)
Consolidated operating earnings		$	97,024			1.96	%			$	88,835			1.85	%
Depreciation and amortization:
Domestic		$	15,038							$	17,971
International		8,865								9,638
CPS		4,440								4,341
Consolidated depreciation and amortization		$	28,343							$	31,950
Capital expenditures:
Domestic		$	7,202							$	11,358
International		4,830								10,790
CPS		1,427								677
Consolidated capital expenditures		$	13,459							$	22,825
		June 30, 2016								December 31, 2015
Total assets:
Domestic		$	1,752,278							$	1,728,345
International		442,097								464,003
CPS		422,738								420,408
Segment assets		2,617,113								2,612,756
Cash and cash equivalents		138,951								161,020
Consolidated total assets		$	2,756,064							$	2,773,776
(1) The three and six months ended June 30, 2015 included $1.2 million and $4.2 million, respectively in accelerated amortization related to an information system that was replaced.

Owens & Minor, Inc. Net Income Per Common Share (unaudited) (in thousands, except per share data)
		Three Months Ended June 30,								Six Months Ended June 30,
		2016				2015				2016				2015
Numerator:
Net income		$	27,716			$	24,226			$	51,851			$	43,166
Less: income allocated to unvested restricted shares		(281		)		(195		)		(560		)		(359		)
Net income attributable to common shareholders - basic		27,435				24,031				51,291				42,807
Add: undistributed income attributable to unvested restricted shares -basic		72				42				131				63
Less: undistributed income attributable to unvested restricted shares -diluted		(72		)		(42		)		(131		)		(63		)
Net income attributable to common shareholders - diluted		$	27,435			$	24,031			$	51,291			$	42,807
Denominator:
Weighted average shares outstanding — basic		61,502				62,226				61,588				62,281
Dilutive shares - stock options		—				—				—				1
Weighted average shares outstanding — diluted		61,502				62,226				61,588				62,282
Net income per share attributable to common shareholders:
Basic		$	0.45			$	0.39			$	0.83			$	0.69
Diluted		$	0.45			$	0.39			$	0.83			$	0.69

View source version on businesswire.com: http://www.businesswire.com/news/home/20160802006989/en/